Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvina A Fratantoni

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Proteomics. Clinical Applications|December 8, 2010
Comparison of the performance of two affinity depletion spin filters for quantitative proteomics of CSF: Evaluation of sensitivity and reproducibility of CSF analysis using GeLC-MS/MS and spectral countingSilvina A Fratantoni, Sander R Piersma, Connie R Jimenez
Bioorganic & Medicinal Chemistry|July 18, 2006
Synthesis and pharmacological characterization of novel inverse agonists acting on the viral-encoded chemokine receptor US28Janneke W Hulshof, Henry F Vischer, Mark H P Verheij, et al.
Bioorganic & Medicinal Chemistry|December 25, 2009
Identification of novel allosteric nonpeptidergic inhibitors of the human cytomegalovirus-encoded chemokine receptor US28Henry F Vischer, Janneke W Hulshof, Saskia Hulscher, et al.
Scientific Reports|July 25, 2015
MicroRNA-124 and -137 cooperativity controls caspase-3 activity through BCL2L13 in hippocampal neural stem cellsMarijn Schouten, Silvina A Fratantoni, Chantal J Hubens, et al.
Scientific Data|August 17, 2016
Multi-omics profile of the mouse dentate gyrus after kainic acid-induced status epilepticusMarijn Schouten, Pascal Bielefeld, Silvina A Fratantoni, et al.
Bioorganic & Medicinal Chemistry|October 11, 2005
New high affinity H3 receptor agonists without a basic side chainRuengwit Kitbunnadaj, Marcel Hoffmann, Silvina A Fratantoni, et al.
Brain Pathology (Zurich, Switzerland)|October 13, 2011
The proteome of the locus ceruleus in Parkinson's disease: relevance to pathogenesisKarin D van Dijk, Henk W Berendse, Benjamin Drukarch, et al.
Plos One|February 8, 2014
A monoclonal antibody TrkB receptor agonist as a potential therapeutic for Huntington's diseaseDaniel Todd, Ian Gowers, Simon J Dowler, et al.
Science Translational Medicine|December 26, 2014
Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington's diseaseXiao-Hong Lu, Virginia B Mattis, Nan Wang, et al.
American Journal of Human Genetics|September 29, 2009
PPIB mutations cause severe osteogenesis imperfectaFleur S van Dijk, Isabel M Nesbitt, Eline H Zwikstra, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Proteomics. Clinical Applications|December 8, 2010
Comparison of the performance of two affinity depletion spin filters for quantitative proteomics of CSF: Evaluation of sensitivity and reproducibility of CSF analysis using GeLC-MS/MS and spectral countingSilvina A Fratantoni, Sander R Piersma, Connie R Jimenez
Bioorganic & Medicinal Chemistry|July 18, 2006
Synthesis and pharmacological characterization of novel inverse agonists acting on the viral-encoded chemokine receptor US28Janneke W Hulshof, Henry F Vischer, Mark H P Verheij, et al.
Bioorganic & Medicinal Chemistry|December 25, 2009
Identification of novel allosteric nonpeptidergic inhibitors of the human cytomegalovirus-encoded chemokine receptor US28Henry F Vischer, Janneke W Hulshof, Saskia Hulscher, et al.
Scientific Reports|July 25, 2015
MicroRNA-124 and -137 cooperativity controls caspase-3 activity through BCL2L13 in hippocampal neural stem cellsMarijn Schouten, Silvina A Fratantoni, Chantal J Hubens, et al.
Scientific Data|August 17, 2016
Multi-omics profile of the mouse dentate gyrus after kainic acid-induced status epilepticusMarijn Schouten, Pascal Bielefeld, Silvina A Fratantoni, et al.
Bioorganic & Medicinal Chemistry|October 11, 2005
New high affinity H3 receptor agonists without a basic side chainRuengwit Kitbunnadaj, Marcel Hoffmann, Silvina A Fratantoni, et al.
Brain Pathology (Zurich, Switzerland)|October 13, 2011
The proteome of the locus ceruleus in Parkinson's disease: relevance to pathogenesisKarin D van Dijk, Henk W Berendse, Benjamin Drukarch, et al.
Plos One|February 8, 2014
A monoclonal antibody TrkB receptor agonist as a potential therapeutic for Huntington's diseaseDaniel Todd, Ian Gowers, Simon J Dowler, et al.
Science Translational Medicine|December 26, 2014
Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington's diseaseXiao-Hong Lu, Virginia B Mattis, Nan Wang, et al.
American Journal of Human Genetics|September 29, 2009
PPIB mutations cause severe osteogenesis imperfectaFleur S van Dijk, Isabel M Nesbitt, Eline H Zwikstra, et al.
Pageof 1